Position history for CAPITAL FUND MANAGEMENT S.A.'s holdings in ARROWHEAD PHARMACEUTICALS IN
CAPITAL FUND MANAGEMENT S.A. previously held 0 shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), worth $0 as of 2025-Q4.
Final Value
$0
Final Shares
0
Total Value Change
-$965,008
Total Shares Change
-37,130
Other major holders of ARWR: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, BANQUE PICTET & CIE SA
Exited |
| 0 |
-100.0% |
| $0 |
| 0.0% |
| $67.25 |
0 |
| 2025-Q3 | Decreased | 35,140 | -84.5% | $1.2M | 0.0% | $33.78 | 0 |
| 2025-Q2 | Increased | 226,365 | +38.8% | $3.6M | 0.0% | $16.08 | 35 |
| 2025-Q1 | New | 163,146 | - | $2.1M | 0.0% | $13.82 | 36 |
| 2024-Q4 | Exited | 0 | -100.0% | $0 | 0.0% | $18.61 | 0 |
| 2024-Q3 | Increased | 40,984 | +10.4% | $793,860 | 0.0% | $19.67 | 27 |
| 2024-Q2 | New | 37,130 | - | $965,008 | 0.0% | $25.99 | 35 |